INTERFERON THERAPY OF CRYPTOGENIC CHRONIC ACTIVE LIVER-DISEASE AND ITS RELATIONSHIP TO ANTI-HCV

被引：0

作者：

DIODATI, G

BONETTI, P

TAGGER, A

ALBERTI, A

REALDI, G

RUOL, A

机构：

[1] UNIV MILAN,INST VIROL,I-20122 MILAN,ITALY

[2] UNIV SASSARI,MED GEN CLIN,I-07100 SASSARI,ITALY

来源：

ARCHIVES OF VIROLOGY | 1992年

关键词：

D O I：

暂无

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

In a randomized controlled trial of Interferon (IFN) in 60 patients (30 treated and 30 controls) with cryptogenic chronic active liver disease, 70% of treated patients showed complete response, but a high rate of biochemical relapse (62%) was noted. In these cases, a second response to higher doses of IFN has been more difficult and less frequent. A response to IFN was found in 88.5% of anti-HCV positive treated patients and only in 25% of anti-HCV negative. We suggest that serum anti-HCV is a suitable test to predict the response to IFN.

引用

页码：299 / 303

页数：5

共 50 条

[31] ANTI-HCV IGM ANTIBODIES IN CHRONIC HEPATITIS-C AS PREDICTORS OF THE CLINICAL OUTCOME OF INTERFERON THERAPY [J].

MERGENER, K ;

LENNARTZ, L ;

MICHEL, G ;

PELZER, C ;

KORN, A ;

MULLER, R ;

MANNS, M .

HEPATOLOGY, 1992, 16 (04) :A213-A213

[32] DETECTION OF ANTI-INTERFERON-ALPHA-2A ANTIBODIES IN CHRONIC LIVER-DISEASE [J].

IKEDA, Y ;

MIYAKE, K ;

TODA, G ;

YAMADA, H ;

YAMANAKA, M ;

OKA, H .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1989, 4 (05) :411-418

[33] THE SPECTRUM OF CHRONIC ACTIVE LIVER-DISEASE [J].

KAPLAN, MM .

HOSPITAL PRACTICE, 1983, 18 (10) :67-76

[34] MANAGEMENT OF CHRONIC ACTIVE LIVER-DISEASE [J].

PATEL, SA ;

VARGAS, DJ ;

LAYDEN, TJ .

HOSPITAL FORMULARY, 1992, 27 (12) :1178-&

[35] RELATIONSHIP BETWEEN ALCOHOLIC LIVER-DISEASE AND HCV INFECTION [J].

TAKASE, S ;

TAKADA, N ;

SAWADA, M ;

TSUTSUMI, M ;

TAKADA, A .

ALCOHOL AND ALCOHOLISM, 1993, 28 :77-84

[36] INTERFERON-BETA TREATMENT IN CHRONIC LIVER-DISEASE HCV RELATED - STUDY ON 86 PATIENTS [J].

PANELLA, C ;

CONTE, D ;

MARGIOTTA, M ;

RUBINI, F ;

TATULLI, L ;

GUGLIELMI, FW ;

VINCIGUERRA, V ;

FRANCAVILLA, A .

HEPATOLOGY, 1993, 18 (04) :A92-A92

[37] HEPATITIS-C VIRUS-INFECTION AND LIVER-DISEASE IN ALT NORMAL INDIVIDUALS WITH ANTI-HCV POSITIVE [J].

KUBOKI, M ;

SHINZAWA, H ;

ISHIBASHI, M ;

YOSHII, E ;

TAKAHASHI, T ;

IINUMA, K .

GASTROENTEROLOGY, 1993, 104 (04) :A931-A931

[38] ANTIBODIES TO HEPATITIS-C VIRUS (ANTI-HCV) IN ALCOHOLIC LIVER-DISEASE - AN ANALYSIS OF RISK-FACTORS [J].

LEAL, RJ ;

MCHUTCHISON, JG ;

HOUGHTON, M ;

CHOO, OL ;

KUO, G ;

REDEKER, AG .

HEPATOLOGY, 1990, 12 (04) :881-881

[39] Clinical manifestations of HBsAg and anti-HCV negative chronic liver disease in Nagasaki Prefecture, Japan [J].

Omagari, K ;

Komatsu, K ;

Kato, Y ;

Nakata, K ;

Kusumoto, Y ;

Mori, I ;

Furukawa, R ;

Tanioka, H ;

Tajima, H ;

Koga, M ;

Yano, M .

INTERNAL MEDICINE, 1996, 35 (08) :600-604

[40] HCV INFECTION IN HBSAG POSITIVE CHRONIC LIVER-DISEASE [J].

FATUZZO, F ;

MUGHINI, MT ;

CACOPARDO, B ;

LAROSA, R ;

NIGRO, L ;

LUPO, G ;

BRUNO, S ;

ZUCCARELLO, M ;

CALTABIANO, E ;

ZIPPER, F ;

COSENTINO, S ;

RUSSO, R ;

NUNNARI, A .

ARCHIVES OF VIROLOGY, 1992, :325-326

← 1 2 3 4 5 →